Pharmacokinetic and Bioequivalence of Ibuprofen Soft Capsules in Healthy Volunteers
Hou Yannin
Abstract
Hou Yannin
Abstract
Objective:To study pharmacokinetics of ibuprofen soft capsules in healthy human subjects and its bioequivalence.Methods:In a randomized crossover study,18 healthy male volunteers were given a single oral dose of 400mg ibuprofen.The concentration of ibuprofen in plasma was determined by HPLC.The pharmacokinetic parameters were processed by DAS program for statistic analysis.Results:The pharmacokinetic parameters of the test and reference preparations were as follows:cmax were (50.45±7.08)and (45.18±8.01)μg·ml-1; tmax were(0.48±0.21)and(0.68±0.31)h;AUC0-10h were (135.26±20.9)and (140.26±21.72)μg·ml-1·h-1;AUC0-∞ were (139.85±21.45) and (145.46±23.93)μg·ml-1·h-1;t1/2 were (2.06±0.26) and (2.04±0.25) h,respectively.The relative bioavailability of the test preparations was (96.98±10.52).Conclusion:The two preparations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study pharmacokinetics of ibuprofen soft capsules in healthy human subjects and its bioequivalence.Methods:In a randomized crossover study,18 healthy male volunteers were given a single oral dose of 400mg ibuprofen.The concentration of ibuprofen in plasma was determined by HPLC.The pharmacokinetic parameters were processed by DAS program for statistic analysis.Results:The pharmacokinetic parameters of the test and reference preparations were as follows:cmax were (50.45±7.08)and (45.18±8.01)μg·ml-1; tmax were(0.48±0.21)and(0.68±0.31)h;AUC0-10h were (135.26±20.9)and (140.26±21.72)μg·ml-1·h-1;AUC0-∞ were (139.85±21.45) and (145.46±23.93)μg·ml-1·h-1;t1/2 were (2.06±0.26) and (2.04±0.25) h,respectively.The relative bioavailability of the test preparations was (96.98±10.52).Conclusion:The two preparations were bioequivalent.
Key concepts: Bioequivalence, Medicine, Pharmacokinetics, Ibuprofen, Bioavailability, Cmax, Crossover study, Pharmacology